# Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel

> **NCT04892706** · PHASE2 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 686 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** IDP-126 Gel
- **DRUG:** IDP-126 Vehicle Gel
- **DRUG:** Epiduo® Forte Gel

## Key facts

- **NCT ID:** NCT04892706
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-11
- **Primary completion:** 2022-09-28
- **Final completion:** 2022-09-28
- **Target enrollment:** 686 (ACTUAL)
- **Last updated:** 2025-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04892706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04892706, "Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04892706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*